Nexalin Ownership | Who Owns Nexalin?
Nexalin Ownership Summary
Nexalin is owned by 3.71% institutional investors, 23.30% insiders, and 72.99% retail investors. Morgan stanley is the largest institutional shareholder, holding 0.80% of NXL shares.
NXL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nexalin | 3.71% | 23.30% | 72.99% |
| Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
| Industry | Medical Device Stocks | 50.93% | 7.99% | 41.08% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Morgan stanley | 59.80K | 0.80% | $101.07K |
| Cvi | 55.46K | 0.75% | $93.73K |
| Geode capital management | 44.06K | 0.59% | $74.46K |
| Atria wealth solutions | 38.41K | 0.52% | $64.92K |
| Vanguard group | 31.78K | 0.43% | $53.71K |
| State street | 16.80K | 0.23% | $28.39K |
| Tower research capital llc (trc) | 9.87K | 0.13% | $16.68K |
| Ubs group | 4.04K | 0.05% | $6.82K |
| Bank of america corp /de/ | 46.00 | 0.00% | $78.00 |
| Stone house investment management | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cvi | 55.46K | 0.08% | $93.73K |
| Atria wealth solutions | 38.41K | 0.00% | $64.92K |
| Tower research capital llc (trc) | 9.87K | 0.00% | $16.68K |
| Jane street group | - | - | - |
| State street | 16.80K | - | $28.39K |
| Squarepoint ops | - | - | - |
| Ubs group | 4.04K | - | $6.82K |
| Wells fargo & company/mn | - | - | - |
| Citigroup | - | - | - |
| Vanguard group | 31.78K | - | $53.71K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 59.80K | - | 59.80K |
| Cvi | 55.46K | 0.08% | 55.46K |
| Atria wealth solutions | 38.41K | 0.00% | 38.41K |
| Vanguard group | 31.78K | - | 31.78K |
| State street | 16.80K | - | 16.80K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Squarepoint ops | - | - | -12.63K |
| Jane street group | - | - | -11.31K |
| Advisor group | - | - | -3.00K |
| Stone house investment management | - | - | -357.00 |
| Ubs group | 4.04K | - | -132.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Morgan stanley | 59.80K | - | 59.80K | $101.07K |
| Cvi | 55.46K | 0.08% | 55.46K | $93.73K |
| Atria wealth solutions | 38.41K | 0.00% | 38.41K | $64.92K |
| Vanguard group | 31.78K | - | 31.78K | $53.71K |
| State street | 16.80K | - | 16.80K | $28.39K |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -1.00 |
| Wells fargo & company/mn | -44.00 |
| Stone house investment management | -357.00 |
| Advisor group | -3.00K |
| Jane street group | -11.31K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 13 | 160.00% | 276,263 | 335.29% | 3 | 510.07% | 12 | 200.00% | 1 | - |
| Mar 31, 2024 | 5 | 66.67% | 63,466 | 32.28% | - | 203.86% | 4 | 100.00% | - | - |
| Dec 31, 2023 | 3 | -40.00% | 47,980 | -40.94% | - | 52.04% | 2 | -60.00% | - | - |
| Sep 30, 2023 | 5 | 25.00% | 81,246 | 558.50% | 1 | 3889.55% | 5 | 400.00% | - | -100.00% |
| Jun 30, 2023 | 4 | -42.86% | 12,338 | -78.61% | - | 27.02% | 1 | -75.00% | 2 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 28, 2024 | Owens David | Chief Medical Officer | Buy | $1.09K |
| Sep 28, 2022 | Elson Marilyn | - | Buy | $149.40K |
| Aug 13, 2024 | Owens David | Chief Medical Officer | Buy | $950.00 |
| Jun 28, 2024 | Owens David | Chief Medical Officer | Buy | $1.75K |
| Jun 18, 2024 | Owens David | Chief Medical Officer | Buy | $1.15K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 1 | - |
| 2024 Q3 | 1 | - |
| 2024 Q2 | 4 | - |
| 2022 Q3 | 16 | - |
| 2007 Q2 | - | - |
NXL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools